Inspire Medical price target lowered to $175 from $190 at Stifel

Stifel lowered the firm’s price target on Inspire Medical (INSP) to $175 from $190 and keeps a Hold rating on the shares. While Inspire’s valuation has “become more attractive of late” and the company “appears well positioned for any tariff twists and turns,” the firm sees some “choppy waters ahead” and believes news flow might act as an overhang to Inspire shares over the next six months, the analyst tells investors.